---
title: "Windtree Therapeutics, Inc. (WINT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WINT.US.md"
symbol: "WINT.US"
name: "Windtree Therapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T10:41:16.802Z"
locales:
  - [en](https://longbridge.com/en/quote/WINT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WINT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WINT.US.md)
---

# Windtree Therapeutics, Inc. (WINT.US)

## Company Overview

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [windtreetx.com](https://windtreetx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 0.00 | 65 | - | - | - |
| PB | -0.02 | 451 | 0.51 | 0.27 | 0.22 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/WINT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/WINT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/WINT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/WINT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**